|
FANCG expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.301580E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.603500E-03 |
| Normal-vs-Stage2 |
3.582000E-04 |
| Normal-vs-Stage3 |
1.643620E-03 |
| Normal-vs-Stage4 |
6.536000E-02 |
| Stage1-vs-Stage2 |
6.146200E-02 |
| Stage1-vs-Stage3 |
2.235200E-01 |
| Stage1-vs-Stage4 |
9.075800E-01 |
| Stage2-vs-Stage3 |
3.250800E-01 |
| Stage2-vs-Stage4 |
8.991600E-02 |
| Stage3-vs-Stage4 |
3.081200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.396800E-03 |
| Normal-vs-AfricanAmerican |
3.338400E-01 |
| Normal-vs-Asian |
2.322400E-01 |
| Caucasian-vs-AfricanAmerican |
4.924000E-01 |
| Caucasian-vs-Asian |
8.39450000000852E-05 |
| AfricanAmerican-vs-Asian |
6.864100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.430400E-02 |
| Normal-vs-Female |
8.551200E-04 |
| Male-vs-Female |
3.796600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.671900E-02 |
| Normal-vs-Age(41-60Yrs) |
3.779000E-03 |
| Normal-vs-Age(61-80Yrs) |
2.258000E-03 |
| Normal-vs-Age(81-100Yrs) |
3.455600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.622600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.488840E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.581400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.748600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.137400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.259400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.546200E-02 |
| Classical-VS-Follicular |
4.23429999996117E-06 |
| Classical-VS-Other |
8.078200E-01 |
| Classical-VS-Normal |
1.053650E-01 |
| Tall-VS-Follicular |
4.672200E-02 |
| Tall-VS-Other |
6.323400E-01 |
| Tall-VS-Normal |
3.122100E-03 |
| Follicular-VS-Other |
2.153800E-01 |
| Follicular-VS-Normal |
5.63369999984076E-07 |
| Other-VS-Normal |
3.572600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.260610E-03 |
| Normal-vs-N1 |
1.983320E-03 |
| N0-vs-N1 |
5.587600E-01 |
|
|
